Please provide your email address to receive an email when new articles are posted on . The rate of eGFR decline accelerated as the age of CKD onset decreased in Black veterans. Younger Black patients ...

Compared with placebo, semaglutide lowered risks for adverse kidney outcomes and mortality across the chronic kidney disease spectrum, according to study data published in Clinical Journal of the ...

If renin-angiotensin system inhibitors are indicated in patients with advanced CKD, they should not be stopped just because of low eGFR, investigators concluded. Discontinuing renin-angiotensin system ...

Kidney disease is common in adults, and testing for kidney disease is part of routine clinical practice for patients with acute or chronic illness. The initial evaluation includes determination of the ...

Digital technologies are making it easier for patients and care givers to manage many chronic health conditions which require ongoing monitoring. Due to lack of innovation, however, chronic kidney ...

A 16-µg dose of lubiprostone, a medication used in the management of constipation, improved or preserved estimated glomerular filtration rate (eGFR) in patients with chronic kidney disease (CKD), ...

Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization's updated clinical practice guideline. In a synopsis of the recently ...

Evaluation of Cockcroft-Gault (CG) and abbreviated modified diet in renal disease (MDRD) formulae in dosing of cancer drugs other than carboplatin No significant financial relationships to disclose.

In a study, higher intake of processed meats led to a nearly 70% increase in CVD mortality. For years, dietary recommendations have focused on reducing saturated fat and its potential sources. For ...

Chronic kidney disease (CKD) had no impact on the efficacy or safety of the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin (Jardiance, Boehringer Ingelheim) for patients with heart ...